[The efficacy of leukinferon in suppurative-septic diseases].
In the complex of treatment of purulent-septic diseases leukinferon at a dose of 300 IU/kg was used according to the following scheme: 3 injections with the 48 h interval between injections. The effect of leukinferon mainly on the function of neutrophil granulocytes and subpopulation of T-lymphocytes was established. Together with clinico-laboratory data indicative of the effectiveness of treatment, normalization of interferon status and decrease in the level of a circulating factor of tumour necrosis in seriously ill patients was observed.
Spivak
N Ia
NIa
Ganova
L A
LA
Iakovenko
L F
LF
Kravchuk
B A
BA
Makarov
A V
AV
Krivokhatskaia
L D
LD
Simonova
A A
AA
Belotskiĭ
S M
SM
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D016207:Cytokines / Q000627:therapeutic use*; D004338:Drug Combinations; D005490:Focal Infection / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D018805:Sepsis / Q000276:immunology / Q000628:therapy*; D014946:Wound Infection / Q000276:immunology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D016207:Cytokines; D004338:Drug Combinations; D007370:Interferon Type I; C062252:leukinferon
Effektivnost' leĭkinferona pri gnoĭno-septicheskikh zabolevaniiakh.